Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280

L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension

(2012) Chika Ogura et al.   BLOOD PRESSURE

Novel approaches to flavivirus drug discovery

(2012) Carolyn Botting et al.   Expert Opinion on Drug Discovery

Monoclonal Antibodies Against NS3 and NS5 Proteins of Japanese Encephalitis Virus

(2012) Zheng Chen et al.   HYBRIDOMA

Enzymatic Analysis of Recombinant Japanese Encephalitis Virus NS2B(H)-NS3pro Protease with Fluorogenic Model Peptide Substrates

(2012) Muhammad Junaid et al.   PLoS One

Identification of a Small-Molecule Entry Inhibitor for Filoviruses

(2011) A. Basu et al.   JOURNAL OF VIROLOGY

First Specific Drugs Raise Hopes for Hepatitis C

(2011) M. Enserink   SCIENCE

Strategies for development of dengue virus inhibitors

(2010) Christian G. Noble et al.   ANTIVIRAL RESEARCH

N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo

(2008) Liba Sebastian et al.   Virology Journal

Does antiviral therapy have a role in the control of Japanese encephalitis?

(2007) E.A. Gould et al.   ANTIVIRAL RESEARCH